Genetic Signatures Limited

ASX:GSS.AX

0.655 (AUD) • At close October 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q2
Revenue 6.1623.6046.53410.40513.58321.8389.59118.6938.7312.5322.6113.4562.5362.4582.1321.931.7611.5051.160.2610.8520000
Cost of Revenue 13.23713.04815.45914.21913.21314.99611.07412.948.6934.9354.3721.4371.0070.9751.0010.7230.4660.550.4890.0990.2570000
Gross Profit -7.075-9.444-8.925-3.8140.376.842-1.4835.7530.038-2.403-1.7612.0191.5281.4831.1311.2071.2950.9550.6710.1620.5950000
Gross Profit Ratio -1.148-2.62-1.366-0.3670.0270.313-0.1550.3080.004-0.949-0.6740.5840.6030.6030.530.6260.7350.6350.5780.6210.6990000
Reseach & Development Expenses 0000000000000000000000000
General & Administrative Expenses 00.8630.9960.8550.3530.2110.1810.2180.2350.2080.250.1820.2310.2630.1070.2780.2930.1680.350.5930.0590000
Selling & Marketing Expenses 00.4650.5680.7160.9170.6070.6910.6270.5210.0452.7222.5582.1942.1191.951.5751.9351.811-0.299-0.299-0.2990000
SG&A 3.1572.6573.3713.0572.0512.2041.3711.4711.4831.1151.1082.742.4252.3822.0571.8532.2281.981.4930.2941.040000
Other Expenses 00.0100.152-0.0100.044000000000000000000
Operating Expenses 3.1572.6473.3712.9052.0612.2041.3271.4711.4831.1151.1083.7683.3113.1832.7132.5462.82.5672.0130.2941.9530000
Operating Income -10.232-12.091-12.296-6.719-1.6914.638-2.814.282-1.445-3.518-2.868-1.749-1.698-1.7-1.444-1.339-1.386-1.612-1.228-0.777-1.3580000
Operating Income Ratio -1.66-3.355-1.882-0.646-0.1240.212-0.2930.229-0.166-1.389-1.098-0.506-0.67-0.692-0.677-0.694-0.787-1.071-1.058-2.978-1.5930000
Total Other Income Expenses Net 0.2770.1920.3030.2390.0530.0630.0690.2150.2510.0720.07900.145-00.113-0-0.028-0.001-0.0740.11200000
Income Before Tax -9.955-11.899-11.993-6.48-1.6384.701-2.7414.497-1.194-3.446-2.79-1.749-1.554-1.7-1.331-1.34-1.414-1.613-1.302-0.665-1.3580000
Income Before Tax Ratio -1.616-3.302-1.835-0.623-0.1210.215-0.2860.241-0.137-1.361-1.068-0.506-0.613-0.692-0.624-0.694-0.803-1.072-1.122-2.549-1.5930000
Income Tax Expense -2.562-1.43-4.42100000-1.454-1.1-1.04700000000.1120.1120.1120000
Net Income -7.393-10.469-7.572-6.48-1.6384.701-2.7414.4970.26-2.346-1.743-1.749-1.554-1.7-1.331-1.34-1.414-1.613-1.302-0.665-1.3580000
Net Income Ratio -1.2-2.905-1.159-0.623-0.1210.215-0.2860.2410.03-0.927-0.667-0.506-0.613-0.692-0.624-0.694-0.803-1.072-1.122-2.549-1.5930000
EPS -0.035-0.073-0.052-0.044-0.0110.032-0.0190.0310.002-0.021-0.016-0.017-0.015-0.016-0.013-0.015-0.02-0.022-0.025-0.013-0.0270000
EPS Diluted -0.035-0.073-0.052-0.044-0.0110.031-0.0190.030.002-0.021-0.016-0.017-0.015-0.016-0.013-0.015-0.019-0.022-0.025-0.013-0.0270000
EBITDA -9.018-11.31-11.472-6.017-0.8895.452-2.044.937-0.957-3.123-2.62-1.527-1.368-1.399-1.194-1.11-1.174-1.424-1.125-0.613-1.2550000
EBITDA Ratio -1.463-3.138-1.756-0.578-0.0650.25-0.2130.264-0.11-1.233-1.003-0.442-0.539-0.569-0.56-0.575-0.667-0.947-0.97-2.351-1.4730000